400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
2023-08-03
免疫细胞疗法开发商
医药研发/制造
化学&生物药
jVen Capital;
jVen Capital;
洲嶺资本;
洲嶺资本;
CAM Capital;
Insight Partners;
RTW Investments;
Northpond Ventures;
Vida Ventures;
Westlake Village BioPartners;
Gilead Sciences;
GordonMD Global Investments;
Bain Capital;
Hudson Bay Capital;
Argentum Peak;
IntelliaTherapeutics;
HealthCor
医麦创新药2026-01-29
医麦创新药2026-01-29
梅花创投2026-01-29
中国药审2026-01-29
中国药审2026-01-29
中国医药生物技术协会2026-01-29
汉氏联合2026-01-29
生物制品圈2026-01-29
生物制品圈2026-01-29
亚太易和2026-01-29